amarogentin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
Studies (amarogentin) | Trials (amarogentin) | Recent Studies (post-2010) (amarogentin) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
---|---|---|---|---|---|
45 | 0 | 35 | 6,010 | 10 | 772 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Das, A; Das, S; Mandal, S; Saha, P | 1 |
1 other study(ies) available for amarogentin and 9,10-dimethyl-1,2-benzanthracene
Article | Year |
---|---|
Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Caspase 3; Cell Proliferation; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Glucosides; In Situ Nick-End Labeling; Iridoids; Male; Medicine, Traditional; Membrane Proteins; Mice; Phytotherapy; Plant Extracts; Skin Neoplasms; Swertia; Up-Regulation | 2006 |